MedPath

Efficacy of Serratus Anterior Plane Block Mastectomy

Not Applicable
Completed
Conditions
Postoperative Complications
Postoperative Pain
Registration Number
NCT03944759
Lead Sponsor
doaa rashwan
Brief Summary

Breast cancer is the main common cancer among females. . Inadequate control of pain may later develop into chronic pain syndrome (paraesthesias, phantom breast pain, and intercostobrachial neuralgia) in 25-40% of the patients .

Detailed Description

The aim of this study is to compare the efficacy of ultrasound-guided serratus anterior plane block with bupivacaine/ magnesium versus bupivacaine/ nalbuphine in breast cancer surgery.

Patients and methods nclusion criteria:

-ASA I and II female patients, age 25-60 undergoing breast cancer surgery

Exclusion criteria:

* Patient refusal

* Contraindications for regional blocks (eg. Infection at the injection site, coagulopathy)

* Allergy to the drugs used in the study

* Chronic pain therapy,

* BMI more than 30 kg/m2

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • ASA I and II female patients, age 25-60 undergoing breast cancer surgery
Exclusion Criteria
  • -Patient refusal
  • Contraindications for regional blocks (eg. Infection at the injection site, coagulopathy)
  • Allergy to the drugs used in the study
  • Chronic pain therapy,
  • BMI more than 30 kg/m2

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
time to first analgesic requirements in minuteschange from base line for 24 hours

time to first analgesic requirements in minutes by the patient

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty Of Medicine, Beni-Suef University

🇪🇬

Banī Suwayf, Egypt

Faculty Of Medicine, Beni-Suef University
🇪🇬Banī Suwayf, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.